168 related articles for article (PubMed ID: 19708542)
1. [New radiopharmaceuticals and positron-emission tomography applications at the Masaryk Memorial Cancer Institute in Brno].
Adam J; Andres P; Bolcák K; Cermáková M; Demlová R; Dubská L; Sedlácková S; Valík D
Klin Onkol; 2009; 22(3):94-7. PubMed ID: 19708542
[TBL] [Abstract][Full Text] [Related]
2. Development and use of non-FDG PET radiopharmaceuticals at the Masaryk Memorial Cancer Institute.
Adam J; Bolcak K; Kaderavek J; Kuzel F
Klin Onkol; 2012; 25 Suppl 2():2S82-6. PubMed ID: 23581022
[TBL] [Abstract][Full Text] [Related]
3. Radionuclide production and yields at Washington University School of Medicine.
Tang L
Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):121-33. PubMed ID: 18043542
[TBL] [Abstract][Full Text] [Related]
4. Non-standard radionuclide production for PET in Japan.
Fujibayashi Y; Suzuki K; Fukumura T; Mori T; Kasamatsu S
Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):140-4. PubMed ID: 18043540
[TBL] [Abstract][Full Text] [Related]
5. Production and separation of ''non-standard'' PET nuclides at a large cyclotron facility: the experiences at the Paul Scherrer Institute in Switzerland.
Hohn A; Zimmermann K; Schaub E; Hirzel W; Schubiger PA; Schibli R
Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):145-50. PubMed ID: 18174878
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography: a first-hand experience.
Traylor J
Radiol Manage; 2000; 22(1):41-7. PubMed ID: 10787761
[TBL] [Abstract][Full Text] [Related]
7. [Current Progresses in Developing PET Radiopharmaceuticals for Patients in the Czech Republic].
Adam J; Demlová R; Řehák Z
Klin Onkol; 2016; 29 Suppl 4():S95-100. PubMed ID: 27846727
[TBL] [Abstract][Full Text] [Related]
8. Decay data and production yields of some non-standard positron emitters used in PET.
Qaim SM
Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):111-20. PubMed ID: 18174879
[TBL] [Abstract][Full Text] [Related]
9. Radiation detector developments in medical applications: inorganic scintillators in positron emission tomography.
van Eijk CW
Radiat Prot Dosimetry; 2008; 129(1-3):13-21. PubMed ID: 18321877
[TBL] [Abstract][Full Text] [Related]
10. [Synthesis of radiopharmaceuticals for PET investigations].
Mikecz P; Tóth G; Horváth G; Lehel S; Kovács Z; Pribóczki E; Boros I; Miklovicz T; Márián T
Orv Hetil; 2002 May; 143(21 Suppl 3):1240-2. PubMed ID: 12077905
[TBL] [Abstract][Full Text] [Related]
11. PET Center - Masaryk Memorial Cancer Institute, Brno, Czech Republic.
Bolcák K
Nucl Med Rev Cent East Eur; 2005; 8(2):160-2. PubMed ID: 16437408
[No Abstract] [Full Text] [Related]
12. [The nuclear medicine department and the TEP/Biomedical Cyclotron unit].
Goldman S; Schoutens A; Blocklet D; Dumarey N; Egrise D; Lipschutz B; Monclus M; Moreno-Reyes R; Schmitz F; Van Naemen J; Wikler D
Rev Med Brux; 2002; 23 Suppl 2():101-5. PubMed ID: 12584923
[TBL] [Abstract][Full Text] [Related]
13. Measurement and control of the air contamination generated in a medical cyclotron facility for PET radiopharmaceuticals.
Calandrino R; del Vecchio A; Todde S; Fazio F
Health Phys; 2007 May; 92(5 Suppl):S70-7. PubMed ID: 17440326
[TBL] [Abstract][Full Text] [Related]
14. Effective production of ⁶⁵Zn with a PET cyclotron.
Lucconi G; Cicoria G; Pancaldi D; Malizia C; Marengo M
Appl Radiat Isot; 2012 Aug; 70(8):1590-4. PubMed ID: 22732395
[TBL] [Abstract][Full Text] [Related]
15. Developing new molecular imaging probes for PET.
Serdons K; Verbruggen A; Bormans GM
Methods; 2009 Jun; 48(2):104-11. PubMed ID: 19318126
[TBL] [Abstract][Full Text] [Related]
16. Cyclotrons and positron emission tomography radiopharmaceuticals for clinical imaging.
Saha GB; MacIntyre WJ; Go RT
Semin Nucl Med; 1992 Jul; 22(3):150-61. PubMed ID: 1523413
[TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography for use in microdosing studies.
Wagner CC; Müller M; Lappin G; Langer O
Curr Opin Drug Discov Devel; 2008 Jan; 11(1):104-10. PubMed ID: 18175273
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical preparation of oxygen-15 labelled molecular oxygen and carbon monoxide gasses in a hospital setting.
Luurtsema G; Boellaard R; Greuter HN; Rijbroek A; Takkenkamp K; de Geest FG; Buijs FL; Harry Hendrikse N; Franssen EJ; van Lingen A; Lammertsma AA
J Clin Pharm Ther; 2010 Feb; 35(1):63-9. PubMed ID: 20175813
[TBL] [Abstract][Full Text] [Related]
19. Peptides, multimers and polymers.
Dijkraaf I; Wester HJ
Handb Exp Pharmacol; 2008; (185 Pt 2):61-92. PubMed ID: 18626599
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and preliminary biological evaluations of [18F]-1-deoxy-1-fluoro-scyllo-inositol.
Vasdev N; Chio J; van Oosten EM; Nitz M; McLaurin J; Vines DC; Houle S; Reilly RM; Wilson AA
Chem Commun (Camb); 2009 Oct; (37):5527-9. PubMed ID: 19753345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
